Tilbæk, S. et al. 2023. Plan robustness evaluation strategies in whole-pelvic proton therapy for high-risk prostate cancer patients within a randomised clinical trial. Acta Oncologica. 62, 11 (Nov. 2023), 1455–1460. DOI:https://doi.org/10.1080/0284186X.2023.2261621.